Dexcom beats the Street with Q2 results

This article was originally published here

 (NSDQ:DXCM) topped sales and earnings expectations on Wall Street today with its second-quarter financial results.

The San Diego, Calif.-based company posted profits of $30.2 million, or 34¢ per share, on sales of $242.5 million for the three months ended June 30, representing a whopping 941% increase in profits and a 42% increase in sales compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post Dexcom beats the Street with Q2 results appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply